THE PROGNOSTIC-SIGNIFICANCE OF THE HALF-LIFE OF SERUM CA-125 IN PATIENTS RESPONDING TO CHEMOTHERAPY FOR EPITHELIAL OVARIAN-CARCINOMA

被引：62
|
作者：
HAWKINS, RE
ROBERTS, K
WILTSHAW, E
MUNDY, J
FRYATT, IJ
MCCREADY, VR
机构：
[1] ROYAL MARSDEN HOSP,DEPT MED,FULHAM RD,LONDON SW3 6JJ,ENGLAND
[2] ROYAL MARSDEN HOSP,DEPT NUCL MED,LONDON SW3 6JJ,ENGLAND
来源：
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1989年 / 96卷 / 12期
关键词：
D O I：
10.1111/j.1471-0528.1989.tb06301.x
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1395 / 1399
页数：5
相关论文
共 50 条
  • [1] PROGNOSTIC-SIGNIFICANCE OF CA-125 HALF-LIFE FOR THE FURTHER OUTCOME OF PATIENTS WITH ADVANCED OVARIAN-CANCER
    MEIER, W
    STIEBER, P
    FATEHMOGHADAM, A
    EIERMANN, W
    HEPP, H
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1992, 52 (09) : 526 - 532
  • [2] THE PROGNOSTIC-SIGNIFICANCE OF CA-125 HALF-LIFE IN PATIENTS WITH OVARIAN-CANCER WHO HAVE RECEIVED PRIMARY CHEMOTHERAPY AFTER SURGICAL CYTOREDUCTION
    HUNTER, VJ
    DALY, L
    HELMS, M
    SOPER, JT
    BERCHUCK, A
    CLARKEPEARSON, DL
    BAST, RC
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (04) : 1164 - 1167
  • [3] IS CA-125 MONITORING USEFUL IN PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA AND PREOPERATIVE NEGATIVE CA-125 SERUM LEVELS
    SEVELDA, P
    ROSEN, A
    DENISON, U
    BARRADA, M
    SPONA, J
    SALZER, H
    GYNECOLOGIC ONCOLOGY, 1991, 43 (02) : 154 - 158
  • [4] EVALUATION OF SERUM CA-125 LEVELS IN THE MONITORING OF RESPONSE TO CHEMOTHERAPY IN EPITHELIAL OVARIAN-CARCINOMA (EOC)
    QUARANTA, M
    COVIELLO, M
    MICELLI, G
    CASAMASSIMA, A
    ABBATE, I
    CORREALE, M
    LORUSSO, V
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 322 - 322
  • [5] CA-125 IN THE MONITORING OF RESPONSE TO CHEMOTHERAPY OF OVARIAN-CARCINOMA
    QUARANTA, M
    LORUSSO, V
    COVIELLO, M
    MICELLI, G
    CASAMASSIMA, A
    INTERNATIONAL JOURNAL OF CANCER, 1988, : 68 - 70
  • [6] A STUDY OF SERUM CASA AND CA-125 LEVELS IN PATIENTS WITH OVARIAN-CARCINOMA
    MEISEL, M
    STRAUBE, W
    WEISE, J
    BURKHARDT, B
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1995, 256 (01) : 9 - 15
  • [7] SERUM HALF-LIFE OF CA-125 DURING EARLY CHEMOTHERAPY AS AN INDEPENDENT PROGNOSTIC VARIABLE FOR PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER - RESULTS OF A MULTICENTRIC ITALIAN STUDY
    GADDUCCI, A
    ZOLA, P
    LANDONI, F
    MAGGINO, T
    SARTORI, E
    BERGAMINO, T
    CRISTOFANI, R
    GYNECOLOGIC ONCOLOGY, 1995, 58 (01) : 42 - 47
  • [8] SERUM HALF-LIFE OF THE TUMOR MARKER CA 125 DURING INDUCTION CHEMOTHERAPY AS A PROGNOSTIC INDICATOR FOR SURVIVAL IN OVARIAN CARCINOMA
    Hogberg, Thomas
    Kagedal, Bertil
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1990, 69 (05) : 423 - 429
  • [9] CA-125 AND MAM-6 IN SERUM AND TUMOR OF PATIENTS WITH OVARIAN-CARCINOMA
    KOLDOVSKY, U
    WARGALLA, U
    HILKENS, J
    FELDHAMMER, B
    KROIZIN, S
    BROSS, M
    HILGERS, J
    TUMORDIAGNOSTIK & THERAPIE, 1986, 7 (03) : 125 - 128
  • [10] THE PROGNOSTIC VALUE OF POST CHEMOTHERAPY SERUM CA-125 IN EPITHELIAL OVARIAN-CANCER
    TEELING, M
    MCGING, P
    CARNEY, DN
    IRISH JOURNAL OF MEDICAL SCIENCE, 1989, 158 (03) : 59 - 62
12345